TSWM
NBRV

Tyler-Stone Wealth Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Tyler-Stone Wealth Management’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4
Closed – – 984
2021
Q4 		$0 Buy
+4
New +$95 ﹤0.01% 948

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tyler-Stone Wealth Management's NBRV Position: Q1 2022 in Review

Tyler-Stone Wealth Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2022, closing a stake of 4 shares.

Tyler-Stone Wealth Management first reported a position in NBRV in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 29 funds tracked by Wall St. Rank hold NBRV as of Q1 2022.

  • Tyler-Stone Wealth Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2022 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 4 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2022.
  • Tyler-Stone Wealth Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2021 and held it in 1 quarter.
  • Tyler-Stone Wealth Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $0 in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2022.

Based on Tyler-Stone Wealth Management's 13F filing for Q1 2022, filed 12 May 2022.